Ball J, Malia R G, Greaves M, Preston F E
Br J Haematol. 1987 Jan;65(1):95-100. doi: 10.1111/j.1365-2141.1987.tb06141.x.
We have studied the factor VIII multimeric structure in four patients with acquired von Willebrand's disease associated with a circulating inhibitor to the factor VIII complex. In three of the four patients tested, the high and medium molecular weights bands were absent when assessed by sodium dodecyl sulphate-agarose electrophoresis. Plasma from the fourth patient contained all the factor VIII multimeric forms, although the high molecular weight bands were markedly decreased in concentration. Intravenous infusion of 1-deamino-(8-D-arginine)-vasopressin (DDAVP) resulted in the appearance of a full complement of multimers in the plasma of the two patients tested. This response was, however, transient and a return to pre-infusion multimeric composition occurred within 2-4 h. In the patients studied, an inhibitor to the factor VIII complex has induced an acquired variant von Willebrand's disease which transiently corrects after the infusion of DDAVP.
我们研究了4例获得性血管性血友病患者的凝血因子VIII多聚体结构,这些患者体内存在针对凝血因子VIII复合物的循环抑制物。在接受检测的4例患者中,有3例通过十二烷基硫酸钠-琼脂糖电泳评估时,高分子量和中分子量条带缺失。第4例患者的血浆中含有所有凝血因子VIII多聚体形式,尽管高分子量条带的浓度明显降低。静脉输注1-去氨基-(8-D-精氨酸)-血管加压素(DDAVP)后,接受检测的2例患者血浆中出现了完整的多聚体补充。然而,这种反应是短暂的,输注后2-4小时内又恢复到输注前的多聚体组成。在所研究的患者中,针对凝血因子VIII复合物的抑制物诱发了获得性变异型血管性血友病,输注DDAVP后可短暂纠正。